Similar articles for PMID: 20841518

Year	Number of Results
1962	1
1996	1
1998	2
1999	2
2001	3
2002	1
2003	3
2004	3
2005	4
2006	5
2007	4
2008	4
2009	5
2010	6
2011	3
2012	2
2013	5
2014	5
2016	2
2017	5
2018	1
2021	1
2023	1
2024	0

1

Mitiglinide: a novel agent for the treatment of type 2 diabetes mellitus.

Phillippe HM, Wargo KA. Phillippe HM, et al. Ann Pharmacother. 2010 Oct;44(10):1615-23. doi: 10.1345/aph.1P136. Epub 2010 Sep 14. Ann Pharmacother. 2010. PMID: 20841518 Review.

2

Mitiglinide for type 2 diabetes treatment.

Phillippe HM, Wargo KA. Phillippe HM, et al. Expert Opin Pharmacother. 2013 Oct;14(15):2133-44. doi: 10.1517/14656566.2013.834048. Epub 2013 Aug 30. Expert Opin Pharmacother. 2013. PMID: 23992284 Review.

3

Mitiglinide: a rapid- and short-acting non-sulfonylurea insulinotropic agent for the treatment of type 2 diabetic patients.

Malaisse WJ. Malaisse WJ. Expert Opin Pharmacother. 2008 Oct;9(15):2691-8. doi: 10.1517/14656566.9.15.2691. Expert Opin Pharmacother. 2008. PMID: 18803455 Review.

4

Insulin detemir--a new basal insulin analog.

Goldman-Levine JD, Lee KW. Goldman-Levine JD, et al. Ann Pharmacother. 2005 Mar;39(3):502-7. doi: 10.1345/aph.1E334. Epub 2005 Jan 18. Ann Pharmacother. 2005. PMID: 15657117 Review.

5

Effects of mitiglinide, a short-acting insulin secretagogue, on daily glycemic variability and oxidative stress markers in Japanese patients with type 2 diabetes mellitus.

Kodani N, Saisho Y, Tanaka K, Kawai T, Itoh H. Kodani N, et al. Clin Drug Investig. 2013 Aug;33(8):563-70. doi: 10.1007/s40261-013-0098-5. Clin Drug Investig. 2013. PMID: 23797928

6

Pleiotropic effects of mitiglinide in type 2 diabetes mellitus.

Konya H, Miuchi M, Konishi K, Nagai E, Ueyama T, Kusunoki Y, Kimura Y, Nakamura Y, Ishikawa T, Inokuchi C, Katsuno T, Hamaguchi T, Miyagawa J, Namba M. Konya H, et al. J Int Med Res. 2009 Nov-Dec;37(6):1904-12. doi: 10.1177/147323000903700628. J Int Med Res. 2009. PMID: 20146890 Free article. Clinical Trial.

7

Effects of combination of mitiglinide with various oral antidiabetic drugs in streptozotocin-nicotinamide-induced type 2 diabetic rats and Zucker fatty rats.

Akahane K, Ojima K, Yokoyama A, Inoue T, Kiguchi S, Tatemichi S, Takeda H, Imai Y. Akahane K, et al. Clin Exp Pharmacol Physiol. 2017 Dec;44(12):1263-1271. doi: 10.1111/1440-1681.12823. Epub 2017 Sep 5. Clin Exp Pharmacol Physiol. 2017. PMID: 28744906

8

Insuline glusine (Apidra): a new rapid-acting insulin.

[No authors listed] [No authors listed] Med Lett Drugs Ther. 2006 Apr 24;48(1233):33-4. Med Lett Drugs Ther. 2006. PMID: 16625142 Review.

9

A review of inhaled technosphere insulin.

Neumiller JJ, Campbell RK, Wood LD. Neumiller JJ, et al. Ann Pharmacother. 2010 Jul-Aug;44(7-8):1231-9. doi: 10.1345/aph.1P055. Epub 2010 Jun 1. Ann Pharmacother. 2010. PMID: 20516362 Review.

10

Repaglinide, a novel, short-acting hypoglycemic agent for type 2 diabetes mellitus.

Guay DR. Guay DR. Pharmacotherapy. 1998 Nov-Dec;18(6):1195-204. Pharmacotherapy. 1998. PMID: 9855316 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

67 results

Results by year